Long-Term Effectiveness of Dupilumab in Moderate-to-Severe Atopic Dermatitis Across Different Body Regions in Extended Dosing-Interval Regimens: A Real-World Chinese Study.

Real-world data on the long-term effectiveness of dupilumab in moderate-to-severe atopic dermatitis (AD) remains limited, particularly concerning regional disparities in improvement and the outcomes of extended dosing interval regimens. To evaluate t…

Preview only. Read the full abstract at the source